Clinical and microbiological aspects of acute community-acquired pneumonia due to Streptococcus pneumoniae;Aspectos clínicos y microbiológicos de la neumonía aguda comunitaria a Streptococcus pneumoniae

Revista Clinica Espanola

Volumn 213, Issue 2, 2013, Pages 88-96

  Cardinal Fernandez P ^a   Gabarrot, G García ^b   Echeverria, P ^c   Zum, G ^d   Hurtado, J ^e   Rieppi, G ^f  

^a CASMU   (Uruguay)

^b Ministerio de Salud Pública ^*  (Uruguay)

^c Servicio de Microbiología   (Uruguay)

^d Hospital Policial   (Uruguay)

^e Hospital Español Juan José Crottoggini   (Uruguay)

^f UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

Community acquired pneumonia; Epidemiology; Mortality; Pneumonia; Serotypes; Streptococcus pneumoniae

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; SEROTYPE; SHOCK; STREPTOCOCCUS PNEUMONIAE; THERAPY DELAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; URUGUAY; YOUNG ADULT;

EID: 84875211356     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2012.09.011     Document Type: Article

References (39)

1. V. Monge, V.M. San-Martín, and A. González The burden of community-acquired pneumonia in spain Eur J Public Health 11 2001 362 364 (Pubitemid 33126476)
2. Ministerio de Salud Pública [consultado 10 Feb 2012]. Disponible en: http://www.msp.gub.uy
3. J. Blanquer, R. Blanquer, R. Borras, D. Nauffal, P. Morales, and R. Menendez Aetiology of community acquired pneumonia in valencia, spain: a multicentre prospective study Thorax 46 1991 508 511
4. C. Feldman, S. Ross, A.G. Mahomed, J. Omar, and C. Smith The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy Respir Med 89 1995 187 192
5. A.B. Carlavilla, F. López-Medrano, F. Chaves, V. Villena, J. Echave-Sustaeta, and J.M. Aguado Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant streptococcus pneumoniae and complicated with empyema Enferm Infecc Microbiol Clin 23 2005 270 273 (Pubitemid 40732892)
6. H. Wang, M. Chen, Y. Xu, H. Sun, Q. Yang, and Y. Hu Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in asia: Report from the community-acquired respiratory tract infection pathogen surveillance (cartips) study, 2009-2010 Int J Antimicrob Agents 38 2011 376 383
7. D.R. Feikin, A. Schuchat, M. Kolczak, N.L. Barrett, L.H. Harrison, and L. Lefkowitz Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997 Am J Public Health 90 2000 223 229 (Pubitemid 30062674)
8. A. Gentile, and V. Bazan Prevention of pneumococcal disease through vaccination Vaccine 29 Suppl. 3 2011 S15 S25
9. Instituto Nacional de Estadítica [consultado 22 May 2012]. Disponible en: http://www.ine.gub.uy
10. T. Camou, R. Palacio, J.L. di Fabio, and M. Hortal Invasive pneumococcal diseases in uruguayan children: comparison between serotype distribution and conjugate vaccine formulations Vaccine 21 2003 2093 2096
11. E. Polverino, and A. Torres Martí Community-acquired pneumonia Minerva Anestesiol 77 2011 196 211
12. A. Fenoll, L. Aguilar, M.J. Giménez, M.D. Vicioso, O. Robledo, and J.J. Granizo Variations in serotypes and susceptibility of adult non-invasive streptococcus pneumoniae isolates between the periods before (may 2000-may 2001) and 10 years after (may 2010-may 2011) introduction of conjugate vaccines for child immunisation in spain Int J Antimicrob Agents 40 2012 18 23
13. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement [consultado 15 Mar 2012]. Disponible en: http://www.rsu.ac.th/medtech/files/CLSI%202011.pdf
14. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean Infectious diseases society of america/american thoracic society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl. 2 2007 S27 S72
15. J.J. Marini, and L. Gattinoni Ventilatory management of acute respiratory distress syndrome: a consensus of two Crit Care Med 32 2004 250 255 (Pubitemid 38125590)
16. R.C. Bone, W.J. Sibbald, and C.L. Sprung The accp-sccm consensus conference on sepsis and organ failure Chest 101 1992 1481 1483
17. W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
18. S.R. Alanee, L. McGee, D. Jackson, C.C. Chiou, C. Feldman, and A.J. Morris Association of serotypes of streptococcus pneumoniae with disease severity and outcome in adults: an international study Clin Infect Dis 45 2007 46 51 (Pubitemid 46984614)
19. M.I. Viciana, M.V. García-López, A. Mariscal, M.A. Sánchez-Bernal, E. Clavijo, and E. Martín Mmicrobiological, clinical and epidemiological aspects of streptococcus pneumoniae isolates recovered over two years Enferm Infecc Microbiol Clin 22 2004 13 17 (Pubitemid 38374121)
20. R. Gil-Prieto, L. García-García, A. àlvaro-Meca, C. Méndez, A. García, and A.G. de Miguel The burden of hospitalisations for community-acquired pneumonia (cap) and pneumococcal pneumonia in adults in spain (2003-2007) Vaccine 29 2011 412 416
21. P.M. Houck, D.W. Bratzler, W. Nsa, A. Ma, and J.G. Bartlett Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia Arch Intern Med 164 2004 637 644 (Pubitemid 38392978)
22. R. Menendez, A. Torres, S. Reyes, R. Zalacaín, A. Capelastegui, and J. Aspa Initial management of pneumonia and sepsis: factors associated with improved outcome Eur Respir J 39 2012 156 162
23. G.W. Waterer, G.W. Somes, and R.G. Wunderink Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia Arch Intern Med 161 2001 1837 1842 (Pubitemid 32762726)
24. J.A. Martínez, J.P. Horcajada, M. Almela, F. Marco, A. Soriano, and E. García Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia Clin Infect Dis 36 2003 389 395 (Pubitemid 36241302)
25. A. Tessmer, T. Welte, P. Martus, M. Schnoor, R. Marre, and N. Suttorp Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia J Antimicrob Chemother 63 2009 1025 1033
26. I. Martín-Loeches, T. Lisboa, A. Rodríguez, C. Putensen, D. Annane, and J. Garnacho-Montero Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia Intensive Care Med 36 2010 612 620
27. S. Ikegaya, K. Inai, H. Iwasaki, H. Naiki, and T. Ueda Azithromycin reduces tumor necrosis factor-alpha production in lipopolysaccharide-stimulated thp-1 monocytic cells by modification of stress response and p38 mapk pathway J Chemother 21 2009 396 402
28. T. Kikuchi, K. Hagiwara, Y. Honda, K. Gomi, T. Kobayashi, and H. Takahashi Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through ap-1 and nf-kappa b transcription factors J Antimicrob Chemother 49 2002 745 755 (Pubitemid 34537634)
29. A.A. Khan, T.R. Slifer, F.G. Araujo, and J.S. Remington Effect of clarithromycin and azithromycin on production of cytokines by human monocytes Int J Antimicrob Agents 11 1999 121 132 (Pubitemid 29114971)
30. H. Oda, J. Kadota, S. Kohno, and K. Hara Leukotriene b4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis Chest 108 1995 116 122
31. S. Kusano, J. Kadota, S. Kohno, K. Iida, K. Kawakami, and T. Morikawa Effect of roxithromycin on peripheral neutrophil adhesion molecules in patients with chronic lower respiratory tract disease Respiration 62 1995 217 222
32. M. Gorrini, A. Lupi, S. Viglio, F. Pamparana, G. Cetta, and P. Iadarola Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics Am J Respir Cell Mol Biol 25 2001 492 499 (Pubitemid 33037682)
33. C. García-Vidal, N. Fernández-Sabe, J. Carratala, V. Díaz, R. Verdaguer, and J. Dorca Early mortality in patients with community-acquired pneumonia: causes and risk factors Eur Respir J 32 2008 733 739
34. W.P. Hausdorff, D.R. Feikin, and K.P. Klugman Epidemiological differences among pneumococcal serotypes Lancet Infect Dis 5 2005 83 93 (Pubitemid 40174779)
35. M. Hortal, T. Camou, R. Palacio, H. Dibarboure, and A. García Ten-year review of invasive pneumococcal diseases in children and adults from uruguay: clinical spectrum, serotypes, and antimicrobial resistance Int J Infect Dis 4 2000 91 95 (Pubitemid 30190770)
36. J. Linares, C. Ardanuy, R. Pallares, and A. Fenoll Changes in antimicrobial resistance, serotypes and genotypes in streptococcus pneumoniae over a 30-year period Clin Microbiol Infect 16 2010 402 410
37. M. Hortal, M. Estevan, H. Laurani, I. Iraola, and M. Meny Hospitalized children with pneumonia in uruguay: pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the national immunization program Vaccine 30 2012 4934 4938
38. F. Braido, M. Bellotti, A. de María, M. Cazzola, and G.W. Canonica The role of pneumococcal vaccine Pulm Pharmacol Ther 21 2008 608 615 (Pubitemid 351970715)
39. S.A. Moberley, J. Holden, D.P. Tatham, and R.M. Andrews Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst Rev 2008 CD000422